Q2 earnings of Orion Pharma increase 42%

Orion Pharma Limited has posted a 42-percent increase in its earnings in the second quarter ended on December 31, 2021 as against the same quarter last year.

Its earnings per share (EPS) stood at Tk 1.72 in the Q2, up from Tk 1.21 recorded in the same period a year earlier, said the company in a filing with the Dhaka Stock Exchange on Monday.

As of December 31, 2021, the company’s net asset value (NAV) per share stood at Tk 80.94 against Tk 79.76 as on June 30, 2021.

Meanwhile, the company had consolidated earnings per share (EPS) of Tk 2.02 in the first six months of the current financial year (July-December ’21).

The EPS for the same period of the previous financial year was Tk 2.03. As a result, the company’s profit decreased by Tk 0.01 or 0.49 percent.